Top

Clinical Research in Cardiology

Published in:

01-12-2018 | Letter to the Editors

Late migration of Edwards SAPIEN 3 transcatheter heart valves: mechanisms and transcatheter treatment options for a rare phenomenon

Authors: Tobias Rheude, Costanza Pellegrini, Jonathan Michel, Christian Thilo, Michael Joner, Albert Markus Kasel

Published in: Clinical Research in Cardiology | Issue 12/2018

Excerpt

Sirs: …

Frangieh AH, Ott I, Michel J, Shivaraju A, Joner M (2017) Standardized minimalistic transfemoral transcatheter aortic valve replacement (TAVR) using the SAPIEN 3 device: stepwise description, feasibility, and safety … structural. Taylor and Francis. https://doi.org/10.1080/24748706.2017.1358832 CrossRef

Gonska B, Seeger J, Keßler M, von Keil A, Rottbauer W, Wöhrle J (2017) Predictors for permanent pacemaker implantation in patients undergoing transfemoral aortic valve implantation with the Edwards Sapien 3 valve. Clin Res Cardiol 106:590–597CrossRef

Schaefer A, Neumann N, Linder M, Schofer N, Schneeberger Y, Deuschl F et al (2018) Outcomes with a latest generation self-expandable, intra-annular, re-sheathable transcatheter heart valve system: analysis of patients with impaired left ventricular function and determinants for pacemaker implantation. Clin Res Cardiol. https://doi.org/10.1007/s00392-018-1263-x CrossRefPubMed

Schaefer A, Linder M, Treede H, Deuschl F, Schofer N, Seiffert M et al (2016) Applicability of next generation balloon-expandable transcatheter heart valves in aortic annuli exceeding formally approved dimensions. Clin Res Cardiol 105:585–591CrossRef

Ibebuogu UN, Giri S, Bolorunduro O, Tartara P, Kar S, Holmes D et al (2015) Review of reported causes of device embolization following trans-catheter aortic valve implantation. Am J Cardiol 115:1767–1772CrossRef

Shivaraju A, Kodali S, Thilo C, Ott I, Schunkert H, von Scheidt W et al (2015) Overexpansion of the SAPIEN 3 transcatheter heart valve: a feasibility study. JACC Cardiovasc Interv 8:2041–2043CrossRef

Ando T, Briasoulis A, Holmes AA, Taub CC, Takagi H, Afonso L (2016) Sapien 3 versus Sapien XT prosthetic valves in transcatheter aortic valve implantation: a meta-analysis. Int J Cardiol 220:472–478CrossRef

Lauten A, Hamadanchi A, Doenst T, Figulla HR (2013) Late migration of balloon-expandable transcatheter aortic valve. Eur Heart J 34:2509CrossRef

Pang PYK, Chiam PTL, Chua YL, Sin YK (2012) A survivor of late prosthesis migration and rotation following percutaneous transcatheter aortic valve implantation. Eur J Cardiothorac Surg 41:1195–1196CrossRef

10.

Clavel M-A, Dumont E, Pibarot P, Doyle D, De Larochellière R, Villeneuve J et al (2009) Severe valvular regurgitation and late prosthesis embolization after percutaneous aortic valve implantation. Ann Thorac Surg 87:618–621CrossRef

11.

Maeno Y, Abramowitz Y, Jilaihawi H, Israr S, Yoon S, Sharma RP et al (2017) Optimal sizing for SAPIEN 3 transcatheter aortic valve replacement in patients with or without left ventricular outflow tract calcification. EuroIntervention 12:e2177–e2185CrossRef

12.

Kim W-K, Blumenstein J, Liebetrau C, Rolf A, Gaede L, Van Linden A et al (2017) Comparison of outcomes using balloon-expandable versus self-expanding transcatheter prostheses according to the extent of aortic valve calcification. Clin Res Cardiol 106:995–1004CrossRef

13.

Bernhardt P, Rodewald C, Seeger J, Gonska B, Buckert D, Radermacher M et al (2016) Non-contrast-enhanced magnetic resonance angiography is equal to contrast-enhanced multislice computed tomography for correct aortic sizing before transcatheter aortic valve implantation. Clin Res Cardiol 105:273–278CrossRef

14.

Mohty D, Pradel S, Magne J, Fadel B, Boulogne C, Petitalot V et al (2017) Prevalence and prognostic impact of left-sided valve thickening in systemic light-chain amyloidosis. Clin Res Cardiol 106:331–340CrossRef

15.

Salzwedel A, Reibis R, Wegscheider K, Eichler S, Buhlert H, Kaminski S et al (2016) Cardiopulmonary exercise testing is predictive of return to work in cardiac patients after multicomponent rehabilitation. Clin Res Cardiol 105:257–267CrossRef

Title: Late migration of Edwards SAPIEN 3 transcatheter heart valves: mechanisms and transcatheter treatment options for a rare phenomenon
Authors: Tobias Rheude
Costanza Pellegrini
Jonathan Michel
Christian Thilo
Michael Joner
Albert Markus Kasel
Publication date: 01-12-2018
Publisher: Springer Berlin Heidelberg
Published in: Clinical Research in Cardiology / Issue 12/2018
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI: https://doi.org/10.1007/s00392-018-1301-8

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Late migration of Edwards SAPIEN 3 transcatheter heart valves: mechanisms and transcatheter treatment options for a rare phenomenon

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 12/2018

ICD lead type and RV lead position in CRT-D recipients

Double-chambered left ventricle in a patient with chest pain

Collagen biomarker bioprofiles predicting the antifibrotic response to eplerenone in myocardial infarction: findings from the REMINDER trial

Cardiac surgery 2017 reviewed

Patent foramen ovale closure for patients excluded from the randomized cryptogenic stroke trials

Changes in arterial pressure hemodynamics in response to renal nerve stimulation both before and after renal denervation

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page